Jürgen Mattern

Synergistic Activity of Sorafenib and Sulforaphane Abolishes Pancreatic Cancer Stem Cell Characteristics

Vanessa Rausch, Li Liu, Georgios Kallifatidis et al. · Cancer Research · 2010 · 208 citations

Chemoprevention Strategy, Immunology, So Administration +16

Prediction of Broad Spectrum Resistance of Tumors towards Anticancer Drugs

Thomas Efferth, V. Badireenath Konkimalla, Yi‐Fen Wang et al. · Clinical Cancer Research · 2008 · 166 citations · Full text

CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non‐small cell lung cancer patients

Alexei V. Salnikov, Jury Gladkich, Gerhard Moldenhauer et al. · International Journal of Cancer · 2009 · 163 citations · Full text

Cancer Stem Cell, Immunology, Nsclc Tissues +16

Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma.

M Volm, E W Hahn, Jürgen Mattern et al. · PubMed · 1988 · 140 citations

Surgical Oncology, Medicine, Five-year Follow-up Study +14

Triptolide reverses hypoxia‐induced epithelial–mesenchymal transition and stem‐like features in pancreatic cancer by NF‐κB downregulation

Li Liu, Alexei V. Salnikov, Nathalie Bauer et al. · International Journal of Cancer · 2013 · 140 citations · Full text

Chemoprevention Strategy, Immunology, Pathology +21